In vitro effects of exercise on the heart

Life Sciences

Volumn 116, Issue 2, 2014, Pages 67-73

  Youtz, Dane J ^a   Isfort, Michael C ^b   Eichenseer, Clayton M ^a   Nelin, Timothy D ^b   Wold, Loren E ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Exercise; Heart; Hypertrophy; Myocyte; Signaling mechanisms

Indexed keywords

ANGIOTENSIN RECEPTOR; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CARDIOTROPHIN 1; CARNITINE PALMITOYLTRANSFERASE; DYXIN; G PROTEIN COUPLED RECEPTOR; INTEGRIN; JANUS KINASE; MICRORNA; MICRORNA 1; MICRORNA 125B; MICRORNA 133; MICRORNA 21; MICRORNA 23A; MITOFUSIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; QUERCETIN; RAF PROTEIN; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; SIMVASTATIN; SIRTUIN 1; STAT PROTEIN; UNCLASSIFIED DRUG; VASOPRESSIN; VASOPRESSIN RECEPTOR; [4 [2 (3 FLUORO 4 TRIFLUOROMETHYLPHENYL) 4 METHYL 5 THIAZOLYLMETHYLTHIO] 2 METHYLPHENOXY]ACETIC ACID;

EXERCISE; EXTRACELLULAR MATRIX; HEART; HEART HYPERTROPHY; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HUMAN; IN VITRO STUDY; MECHANICAL STRESS; MECHANORECEPTOR; MUSCLE HYPERTROPHY; MYOTUBE; NONHUMAN; PHYSICAL STRESS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; ADULT; ANIMAL; BIOLOGICAL MODEL; CARDIOMEGALY; DISEASE MODEL; HEART MUSCLE CELL; HEART OUTPUT; HEART VENTRICLE REMODELING; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

ADULT; ANIMALS; CARDIAC OUTPUT; CARDIOMEGALY; DISEASE MODELS, ANIMAL; EXERCISE; HUMANS; MODELS, BIOLOGICAL; MUSCLE FIBERS, SKELETAL; MYOCYTES, CARDIAC; VENTRICULAR REMODELING;

EID: 84908007015     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.08.015     Document Type: Review

References (51)

1. S.P. Barry, P.A. Townsend, D.S. Latchman, and A. Stephanou Role of the JAK-STAT pathway in myocardial injury Trends Mol Med 13 2007 82 89
2. B.C. Bernardo, K.L. Weeks, L. Pretorius, and J.R. McMullen Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies Pharmacol Ther 128 2010 191 227
3. J.M. Berry, R.H. Naseem, B.A. Rothermel, and J.A. Hill Models of cardiac hypertrophy and transition to heart failure Drug Discov Today Dis Models 4 2007 197 206
4. R.K. Birla, D.E. Dow, Y.-C. Huang, F. Migneco, L. Khait, and G.H. Borschel Methodology for the formation of functional, cell-based cardiac pressure generation constructs in vitro In Vitro Cell Dev Biol Anim 44 2008 340 350
5. E. Blaauw, F.A. van Nieuwenhoven, P. Willemsen, T. Delhaas, F.W. Prinzen, and L.H. Snoeckx Stretch-induced hypertrophy of isolated adult rabbit cardiomyocytes Am J Physiol Heart Circ Physiol 299 2010 H780 H787
6. M. Brancaccio, E. Hirsch, A. Notte, G. Selvetella, G. Lembo, and G. Tarone Integrin signalling: the tug-of-war in heart hypertrophy Cardiovasc Res 70 2006 422 433
7. A. Carè, D. Catalucci, F. Felicetti, D. Bonci, A. Addario, and P. Gallo MicroRNA-133 controls cardiac hypertrophy Nat Med 13 2007 613 618
8. A.F. Ceylan-Isik, M. Dong, Y. Zhang, F. Dong, S. Turdi, and S. Nair Cardiomyocyte-specific deletion of endothelin receptor A rescues aging-associated cardiac hypertrophy and contractile dysfunction: role of autophagy Basic Res Cardiol 108 2013 335
9. G.T. Cooper Cardiocyte adaptation to chronically altered load Annu Rev Physiol 49 1987 501 518
10. D.F. Dai, S.C. Johnson, J.J. Villarin, M.T. Chin, M. Nieves-Cintron, and T. Chen Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure Circ Res 108 2011 837 846
11. A. D'Andrea, P. Caso, R. Scarafile, G. Salerno, G. De Corato, and C. Mita Biventricular myocardial adaptation to different training protocols in competitive master athletes Int J Cardiol 115 2007 342 349
12. L. Fang, X.-L. Moore, X.-M. Gao, A.M. Dart, Y.L. Lim, and X.-J. Du Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo Life Sci 80 2007 2154 2160
13. T. Fernandes, U.P.R. Soci, and E.M. Oliveira Eccentric and concentric cardiac hypertrophy induced by exercise training: microRNAs and molecular determinants Braz J Med Biol Res 44 2011 836 847
14. D. Frank, R. Frauen, C. Hanselmann, C. Kuhn, R. Will, and J. Gantenberg Lmcd1/Dyxin, a novel Z-disc associated LIM protein, mediates cardiac hypertrophy in vitro and in vivo J Mol Cell Cardiol 49 2010 673 682
15. H. Fujita, T. Nedachi, and M. Kanzaki Accelerated de novo sarcomere assembly by electric pulse stimulation in C2C12 myotubes Exp Cell Res 313 2007 1853 1865
16. W.H. Gaasch, and M.R. Zile Left ventricular diastolic dysfunction and diastolic heart failure Annu Rev Med 55 2004 373 394
17. X.T. Gan, V. Rajapurohitam, J.V. Haist, P. Chidiac, M.A. Cook, and M. Karmazyn Inhibition of phenylephrine-induced cardiomyocyte hypertrophy by activation of multiple adenosine receptor subtypes J Pharmacol Exp Ther 312 2005 27 34
18. J.B. Garlie, T. Hamid, Y. Gu, M.A. Ismahil, B. Chandrasekar, and S.D. Prabhu Tumor necrosis factor receptor 2 signaling limits β-adrenergic receptor-mediated cardiac hypertrophy in vivo Basic Res Cardiol 106 2011 1193 1205
19. S. Gielen, G. Schuler, and V. Adams Cardiovascular effects of exercise training: molecular mechanisms Circulation 122 2010 1221 1238
20. M.-C. Gomez-Cabrera, E. Domenech, and J. Viña Moderate exercise is an antioxidant: upregulation of antioxidant genes by training Free Radic Biol Med 44 2008 126 131
21. M.C. Gomez-Cabrera, E. Domenech, and J. Vina Moderate exercise is an antioxidant: upregulation of antioxidant genes by training Free Radic Biol Med 44 2008 126 131
22. B.J. Gurd, Y. Yoshida, J. Lally, G.P. Holloway, and A. Bonen The deacetylase enzyme SIRT1 is not associated with oxidative capacity in rat heart and skeletal muscle and its overexpression reduces mitochondrial biogenesis J Physiol 587 2009 1817 1828
23. J. Heineke, and J.D. Molkentin Regulation of cardiac hypertrophy by intracellular signalling pathways Nat Rev Mol Cell Biol 7 2006 589 600
24. M. Hiroyama, S. Wang, T. Aoyagi, R. Oikawa, A. Sanbe, and S. Takeo Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice Eur J Pharmacol 559 2007 89 97
25. M. Hoshijima Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures Am J Physiol Heart Circ Physiol 290 2006 H1313 H1325
26. S. Jard, R. Gaillard, G. Guillon, J. Marie, P. Shoenenberg, and A. Muller Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis Mol Pharmacol 30 1986 171 177
27. D. Jeong, H. Cha, E. Kim, M. Kang, D.K. Yang, and J.M. Kim PICOT inhibits cardiac hypertrophy and enhances ventricular function and cardiomyocyte contractility Circ Res 99 2006 307 314
28. H. Lal, S.K. Verma, M. Smith, R.S. Guleria, G. Lu, and D.M. Foster Stretch-induced MAP kinase activation in cardiac myocytes: differential regulation through beta1-integrin and focal adhesion kinase J Mol Cell Cardiol 43 2007 137 147
29. L. Lin, H. Gong, J. Ge, G. Jiang, N. Zhou, and L. Li High density lipoprotein downregulates angiotensin II type 1 receptor and inhibits angiotensin II-induced cardiac hypertrophy Biochem Biophys Res Commun 404 2011 28 33
30. J. Liu, Q. Shen, and Y. Wu Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway Life Sci 82 2008 991 996
31. M.L. McCain, and K.K. Parker Mechanotransduction: the role of mechanical stress, myocyte shape, and cytoskeletal architecture on cardiac function Pflugers Arch Eur J Physiol 462 2011 89 104
32. M. Methawasin, K.R. Hutchinson, E.J. Lee, J.E. Smith III, C. Saripalli, and C.G. Hidalgo Experimentally increasing titin compliance in a novel mouse model attenuates the Frank-Starling mechanism but has a beneficial effect on diastole Circulation 129 2014 1924 1936
33. T. Nedachi, H. Fujita, and M. Kanzaki Contractile C2C12 myotube model for studying exercise-inducible responses in skeletal muscle Am J Physiol Endocrinol Metab 295 2008 E1191 E1204
34. N. Nikolić, S.S. Bakke, E.T. Kase, I. Rudberg, I. Flo Halle, and A.C. Rustan Electrical pulse stimulation of cultured human skeletal muscle cells as an in vitro model of exercise PLoS One 7 2012 e33203-e
35. D.M. Pedrotty, R.Y. Klinger, N. Badie, S. Hinds, A. Kardashian, and N. Bursac Structural coupling of cardiomyocytes and noncardiomyocytes: quantitative comparisons using a novel micropatterned cell pair assay Am J Physiol Heart Circ Physiol 295 2008 H390 H400
36. D.R. Pimentel, T. Adachi, Y. Ido, T. Heibeck, B. Jiang, and Y. Lee Strain-stimulated hypertrophy in cardiac myocytes is mediated by reactive oxygen species-dependent Ras S-glutathiolation J Mol Cell Cardiol 41 2006 613 622
37. H. Reinecke, G.H. MacDonald, S.D. Hauschka, and C.E. Murry Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair J Cell Biol 149 2000 731 740
38. S. Rimbaud, H. Sanchez, A. Garnier, D. Fortin, X. Bigard, and V. Veksler Stimulus specific changes of energy metabolism in hypertrophied heart J Mol Cell Cardiol 46 2009 952 959
39. S. Rimbaud, H. Sanchez, A. Garnier, D. Fortin, X. Bigard, and V. Veksler Stimulus specific changes of energy metabolism in hypertrophied heart J Mol Cell Cardiol 46 2009 952 959
40. B. Russell, M.W. Curtis, Y.E. Koshman, and A.M. Samarel Mechanical stress-induced sarcomere assembly for cardiac muscle growth in length and width J Mol Cell Cardiol 48 2010 817 823
41. J. Schilling, and D.P. Kelly The PGC-1 cascade as a therapeutic target for heart failure J Mol Cell Cardiol 51 2011 578 583
42. A.J.T. Schuldt, M.R. Rosen, G.R. Gaudette, and I.S. Cohen Repairing damaged myocardium: evaluating cells used for cardiac regeneration Curr Treat Options Cardiovasc Med 10 2008 59 72
43. A.L. Serrano, B. Baeza-Raja, E. Perdiguero, M. Jardí, and P. Muñoz-Cánoves Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy Cell Metab 7 2008 33 44
44. L. Sheng, P. Ye, Y.-X. Liu, C.-G. Han, and Z.-Y. Zhang Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro Clin Exp Hypertens 30 2008 109 119
45. L.Q. Stewart, J.A. Roper, W.S. Young III, A.M. O'Carroll, and S.J. Lolait Pituitary-adrenal response to acute and repeated mild restraint, forced swim and change in environment stress in arginine vasopressin receptor 1b knockout mice J Neuroendocrinol 20 2008 597 605
46. M. Tatsuguchi, H.Y. Seok, T.E. Callis, J.M. Thomson, J.-F. Chen, and M. Newman Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy J Mol Cell Cardiol 42 2007 1137 1141
47. M. Thibonnier, C. Auzan, Z. Madhun, P. Wilkins, L. Berti-Mattera, and E. Clauser Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor J Biol Chem 269 1994 3304 3310
48. M. Tian, M.L. Asp, Y. Nishijima, and Ma Belury Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice Int J Oncol 39 2011 1321 1326
49. Y. Wang, U. Wisloff, and O.J. Kemi Animal models in the study of exercise-induced cardiac hypertrophy 8408 2010 633 644
50. N. Yasuda, S.-I. Miura, H. Akazawa, T. Tanaka, Y. Qin, and Y. Kiya Conformational switch of angiotensin II type 1 receptor underlying mechanical stress-induced activation EMBO Rep 9 2008 179 186
51. N. Zhou, L. Li, J. Wu, H. Gong, Y. Niu, and A. Sun Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway Biochem Biophys Res Commun 397 2010 263 269